Comparison of immune response generated against Japanese encephalitis virus envelope protein expressed by DNA vaccines under macrophage associated versus ubiquitous expression promoters
<p>Abstract</p> <p>Background</p> <p>Japanese encephalitis virus (JEV) is the leading cause of viral encephalitis, with ~50,000 cases reported annually worldwide. Vaccination is the only measure for prevention. Recombinant vaccines are an efficient and safe alternative...
Main Authors: | Gore Milind M, Ahsan Mohammad |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-08-01
|
Series: | Virology Journal |
Online Access: | http://www.virologyj.com/content/8/1/382 |
Similar Items
-
Japanese encephalitis virus: Uniqueness of immune response, vaccine development and future challenges
by: Milind M. Gore
Published: (2016-04-01) -
Study of Japanese encephalitis virus DNA vaccine using the transcutaneous immunization
by: Jing-Yan Cheng, et al.
Published: (2007) -
Sequencing of Full-Length cDNA and Expressing Envelope Protein E of Japanese Encephalitis Virus YL Strain
by: TsungHuang Tsai, et al.
Published: (2002) -
Coverage & missed opportunity for Japanese encephalitis vaccine, Gorakhpur division, Uttar Pradesh, India, 2015: Implications for Japanese encephalitis control
by: Manoj V Murhekar, et al.
Published: (2017-01-01) -
Study of Japanese encephalitis virus DNA vaccine using the transcutaneous immunization by chitosan complexes
by: 黃瀚寧
Published: (2008)